An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

Peer Review reports

Original Submission
13 Oct 2020	Submitted	Original manuscript
14 Oct 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
16 Oct 2020	Editorially accepted
26 Oct 2020	Article published	10.1186/s13063-020-04812-2

Back to article page